Frost & Sullivan and DigitalGene.AI jointly release the2026White Paper on Applications of siRNA in the Consumer Sector'Frost & Sullivan' 'Frost & Sullivan China' 'LeadLeo' 'LeadLeo Research Institute' 'LeadLeo' 'YUAN CAPITAL' 'SULLIVAN TELE-TREND CLOUD TECHNOLOGY' 'TradeGo' 'MagnaTEC' 'Automotive & Mobility' 'Environmental Protection & Energy Saving Technology' 'Logistics & Supply Chain' 'MATERNAL AND INFANT' 'Education & Training' 'Real Estate & Property' 'Catering & New Retailing' 'Advanced Materials' 'Healthcare & Life Sciences' 'Semiconductor & Chip' 'COMMERCIAL AVIATION' 'Technology, Media and Telecom' 'LANDSCAPING' 'Big Data & AI' 'Infrastructure Construction & Utilities' 'Culture & Entertainment' 'AGRICULTURE, FORESTRY ANIMAL HUSBANDRY AND FISHERY' 'Food & Beverage' 'Fintech' 'SHIPPING AND PORTS' 'Dual Carbon & New Energy' 'Mining & Metals' 'Public Sector' 'Cross-Border E-commerce Trade' 'Building Technology, Construction & Decoration' 'Beauty & Fashion' 'Smart Homes' 'Digital Infrastructure' 'Enterprise Services' 'Consumer Electronics'
Frost & SullivanandDigitalGene.AI Jointly releases the White Paper on Applications of siRNA in the Consumer Sector 2026"
Over time, traditional active ingredients mainly act at the protein level, making it difficult to precisely address skin issues at their source. siRNA can selectively regulate gene expression, providing a highly specific technological approach for products claiming benefits such as whitening, anti-aging, anti-eczema, sebum control, and hair loss prevention. This white paper focuses on market trends and commercial opportunities for siRNA in the consumer sector, key applications of small nucleic acid technologies in cosmetics, major challenges and regulatory developments in ingredient development and delivery commercialization, and the convergence of gene technology and the beauty industry.
As an AI-driven innovation company, DigitalGene.AI has long focused on "AI + siRNA" foundational technologies. Leveraging capabilities in AI-targeted screening and molecular design, high-throughput experimental validation, and skin delivery, it covers the entire value chain—from target discovery and molecular design to efficacy validation and application development. The company also continues to expand industry partnerships through innovative small nucleic acid ingredients and effective skincare products. Its proprietary ingredients, SciClarity, SciVital, and SciDefend, have already been commercialized in consumer applications, accelerating the shift of siRNA technology from laboratory research to the consumer market.
Looking forward, with continuous improvements in delivery efficiency, efficacy stability, and scalable production capacity, siRNA is expected to unlock greater value in precision skincare and personalized product development.
For years, conventional active ingredients have primarily acted at the protein level, making it difficult to address skin concerns precisely at their source. By selectively regulating gene expression, siRNA offers a highly specific technological pathway for efficacy claims such as brightening, anti-aging, soothing, sebum control and hair-loss prevention. The white paper focuses on market trends and commercial opportunities for siRNA in the consumer sector, key applications of small nucleic acid technologies in cosmetics, major challenges and regulatory developments in ingredient development and delivery commercialization, and the convergence of gene technology and the beauty industry.
As an AI- and data-driven innovation company, DigitalGene.AI has developed deep expertise in foundational "AI + siRNA" technologies. Its capabilities in AI-enabled target screening and molecular design, high-throughput experimental validation and skin delivery span the full value chain—from target discovery and molecular design to efficacy validation and application development. The company also continues to advance industry partnerships in innovative small nucleic acid ingredients and effective skincare products. Its proprietary ingredients, SciClarity, SciVital and SciDefend, have already been commercialized in consumer applications, accelerating the transition of siRNA technology from laboratory research to the consumer market.
Looking ahead, continued improvements in delivery efficiency, efficacy stability and scalable manufacturing are expected to unlock greater value for siRNA in precision skincare and personalized product development.
Click the following link to view a excerpt of the report:
If you have further research needs on the consumer market for small interfering nucleic acids in China, please contact us:
Ms. Stella Liou from Frost & Sullivan
E-mail: stella.liu@frostchina.com
